Opko Health
OPK· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -14.3% in FY2025
Phillip Frost, M.D. is the CEO of Opko Health and was paid $1.9M in FY2025 (Dec), down 14%.
Pay$100 in the stock at the end of FY20 → $32
Executives5
See all- 1Phillip Frost, M.D.Chief Executive OfficerFY2025
- 2Elias A. Zerhouni, M.D.PresidentFY2025
- 3Jane H. Hsiao, Ph.D.Chief Technical OfficerFY2025
- 4Steven D. RubinExecutive Vice President- AdministrationFY2025
- 5Adam LogalSenior Vice President and Chief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allOpko Health paid its 5 named executives $8.5M in total in FY2025 (Dec). CEO Phillip Frost, M.D. was paid $1.9M of that.
| Name | |||
|---|---|---|---|
| Phillip Frost, M.D.Chief Executive Officer | |||
| Elias A. Zerhouni, M.D.President | |||
| Jane H. Hsiao, Ph.D.Chief Technical Officer | |||
| Steven D. RubinExecutive Vice President- Administration | |||
| Adam LogalSenior Vice President and Chief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Opko Health. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board3
See all- Richard C. Pfenniger, Jr.Lead independent director · 17 yr on the boardIndependentAudit (Chair), Succession (Chair)—Paid as an executive
- Jane H. Hsiao, Ph.D.Director · 18 yr on the boardNot independent—Paid as an executive
- Steven D. RubinDirector · 18 yr on the boardNot independent—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 30, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Mar 14, 2025 | FY2024 |
| Annual report | 10-K | Mar 3, 2025 | FY2024 |
| Annual report | 10-K | Mar 1, 2024 | FY2023 |
| Proxy statement | DEF 14A | Feb 29, 2024 | FY2023 |
